Inflamasi Jantung pada Diabetes: Tinjauan Naratif mengenai Siklus Metabolik-Imun dan Cedera Miokardium

Diabetes mellitus is a major metabolic disorder associated with progressive cardiovascular complications, including diabetic cardiomyopathy. Increasing evidence indicates that cardiac inflammation links metabolic stress to myocardial injury and structural remodeling. However, the temporal and causal relationships among these processes, particularly the potential feedback from myocardial injury to metabolic stress, remain incompletely established. Objective: This review synthesizes current evidence on the mechanisms underlying cardiac inflammation in diabetes and proposes an integrated framework linking metabolic, immune, and myocardial respones. Methods: A structured narrative review was conducted with reference to the principles of the Scale for the Assessment of Narrative Review Articles (SANRA). Literature published from January 2020 to July 2026 was identified through PubMed, Scopus, Web of Science, and ScienceDirect using combinations of MeSH and free-text terms related to diabetes, diabetic cardiomyopathy, inflammation, oxidative stress, mitochondrial dysfunction, NLRP3 inflamasome, and pyroptosis. Results: Chronic hyperglycemia and lipotoxicity promote advanced glycation end products, oxidative stress, and mitochondrial dysfunction, which activate RAGE, TLR4, NF-κB, and NLRP3 inflamasome signaling. These pathways promote inflammatory communication among macrophages, cardiomyocytes, and fibroblasts, contributing to pyroptosis, hypertrophy, fibrosis, and myocardial dysfunction. Persistent tissue injury may further amplify local inflammation through damage-associated molecular patterns and mitochondrial danger signals. However, evidence supporting a complete closed positive feedback loop, particularly a causal pathway from myocardial injury back to the initiating metabolic stress, remains limited. Conclusion: The metabolic–immune–myocardial injury cycle is proposed as a conceptual hypothesis to explain the persistence and potential amplification of cardiac inflammation in diabetes. Targeting this interconnected network may provide opportunities for preventing or slowing diabetic cardiomyopathy progression.

Authors

Institutions

Publication Details

Journal
Journal of Pharmaceutical And Sciences
Published
2026-11-14
DOI
https://doi.org/10.36490/journal-jps.com.v9i4.1826
Primary Topic
Cardiac Fibrosis and Remodeling
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Inflamasi Jantung pada Diabetes: Tinjauan Naratif mengenai Siklus Metabolik-Imun dan Cedera Miokardium

Cimi Ilmiawati, Roza Silvia, M. Fitri
Journal of Pharmaceutical And Sciences
Cardiac Fibrosis and Remodeling
article

Inflamasi Jantung pada Diabetes: Tinjauan Naratif mengenai Siklus Metabolik-Imun dan Cedera Miokardium

Cimi Ilmiawati, Roza Silvia, M. Fitri
article en

Abstract

Diabetes mellitus is a major metabolic disorder associated with progressive cardiovascular complications, including diabetic cardiomyopathy. Increasing evidence indicates that cardiac inflammation links metabolic stress to myocardial injury and structural remodeling. However, the temporal and causal relationships among these processes, particularly the potential feedback from myocardial injury to metabolic stress, remain incompletely established. Objective: This review synthesizes current evidence on the mechanisms underlying cardiac inflammation in diabetes and proposes an integrated framework linking metabolic, immune, and myocardial respones. Methods: A structured narrative review was conducted with reference to the principles of the Scale for the Assessment of Narrative Review Articles (SANRA). Literature published from January 2020 to July 2026 was identified through PubMed, Scopus, Web of Science, and ScienceDirect using combinations of MeSH and free-text terms related to diabetes, diabetic cardiomyopathy, inflammation, oxidative stress, mitochondrial dysfunction, NLRP3 inflamasome, and pyroptosis. Results: Chronic hyperglycemia and lipotoxicity promote advanced glycation end products, oxidative stress, and mitochondrial dysfunction, which activate RAGE, TLR4, NF-κB, and NLRP3 inflamasome signaling. These pathways promote inflammatory communication among macrophages, cardiomyocytes, and fibroblasts, contributing to pyroptosis, hypertrophy, fibrosis, and myocardial dysfunction. Persistent tissue injury may further amplify local inflammation through damage-associated molecular patterns and mitochondrial danger signals. However, evidence supporting a complete closed positive feedback loop, particularly a causal pathway from myocardial injury back to the initiating metabolic stress, remains limited. Conclusion: The metabolic–immune–myocardial injury cycle is proposed as a conceptual hypothesis to explain the persistence and potential amplification of cardiac inflammation in diabetes. Targeting this interconnected network may provide opportunities for preventing or slowing diabetic cardiomyopathy progression.

Journal of Pharmaceutical And Sciences
Andalas University (ID)
Cardiac Fibrosis and Remodeling
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon